Phase 2 eNRGy Trial: Zenocutuzumab Shows Efficacy in NRG1 Fusion–Positive NSCLC
Investigating Novel Immunotherapy Combinations for Advanced Gastric and Esophageal Cancers
What’s Next for Adjuvant Therapy in Liver Cancer? Reflections on IMbrave050 and Beyond